表纸
市场调查报告书

实验室自动化系统(LA)的全球市场:2019年~2023年

Global Laboratory Automation Systems Market 2019-2023

出版商 TechNavio (Infiniti Research Ltd.) 商品编码 301119
出版日期 内容资讯 英文 119 Pages
订单完成后即时交付
价格
Back to Top
实验室自动化系统(LA)的全球市场:2019年~2023年 Global Laboratory Automation Systems Market 2019-2023
出版日期: 2019年01月24日内容资讯: 英文 119 Pages
简介

供应商提供软体作为其实验室自动化系统的附加服务,以维持客户忠诚度并确保品质结果。这些软体服务配备了直觀性靈活的用户界面,可以对资料样本进行分析。这些软体服务类似于手动电镀程序。除了符合法规建议,如分析证书(COA)和合格证书(COC)。这些软体服务可以根据最终用户的需求进行更改。其功能多样,可以在不同的平台上运行,如Windows XP、Windows Vista和Windows 7。此类软体服务专为生命科学研究而设计,可增强药物发现过程。另外,这些程式支持即时分析,并以几种常见的文件格式保存和发送数据。具有内置的资料分析计算功能,有助于节省时间并产生高品质的结果,从而推动市场发展。Technavio的分析师预测,到2023年,实验室自动化系统市场的年复合成长率将超过7%。

本报告提供全球实验室自动化系统(LA)市场相关调查分析,市场规模与成长率,市场趋势,市场的推动要素与课题,市场机会验证,再加上主要供应商等相关的系统性资讯。

第1章 摘要整理

第2章 报告的范围

  • 简介1
  • 简介2
  • 美金的货币换算比率

第3章 市场情形

  • 市场生态系统
  • 市场特征
  • 市场区隔分析

第4章 市场规模

  • 市场定义
  • 市场规模(2018年)
  • 市场规模及预测(2018年~2023年)

第5章 波特的五力分析

  • 买主谈判力
  • 供应商谈判力
  • 新加入厂商的威胁
  • 替代品的威胁
  • 竞争对手的威胁
  • 市场情况

第6章 市场区隔:各终端用户

  • 市场区隔:各终端用户
  • 各终端用户比较:市场规模及预测(2018年~2023年)
  • 制药及生物科技企业
  • 临床检验研究所
  • 学术机构及研究机关
  • 市场机会:各终端用户

第7章 客户形势

第8章 地区形势

  • 各地区市场区隔
  • 各地区比较:市场规模及预测(2018年~2023年)
  • 北美
  • 欧洲
  • 亚洲
  • 其他地区
  • 主要国家
  • 市场机会

第9章 决策架构

第10章 成长要素与课题

  • 市场成长要素
  • 市场课题

第11章 市场趋势

第12章 业者情势

  • 概要
  • 创造性破坏状况

第13章 供应商分析

  • 交易厂商
  • 供应商分类
  • 供应商的市场定位
  • Agilent Technologies
  • Danaher
  • PerkinElmer
  • QIAGEN
  • Thermo Fisher Scientific

第14章 附录

  • 调查方法
  • 简称的清单

第15章 关于TECHNAVIO

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: IRTNTR30736

About this market

Vendors have started offering software as an additional service with their laboratory automation systems, to maintain customer loyalty and ensure quality results. These software services are equipped with an intuitive and flexible user interface, which enables the analysis of data sample. These software services resemble the manual plating procedure. Apart from being compliant with regulatory recommendations such as the Certificates of Analysis (COA) and the Certificates of Conformance (COC). These software services can be altered according to the needs of end-users. It is versatile and can run on different platforms such as Windows XP, Windows Vista: and Windows 7. Such software services have been designed specifically for life sciences research and enhance the drug discovery process. Additionally, these programs support real-time analysis and save and send the data in several common file formats. They have built-in calculations for data analysis and help save time and generate high-quality results, thereby driving the market. Technavio's analysts have predicted that the laboratory automation systems market will register a CAGR of over 7% by 2023.

Market Overview

Rising use of automated solutions in healthcare

Fully automated laboratory solutions can help save cost and generate accurate results. Automated solutions can also help save the time of healthcare professionals, as automation replaces manually intensive tasks: which allows researchers to devote more time to analysis and data interpretation. Automation solutions in healthcare, which include automated systems, software, and other services, also improve laboratory productivity, as they reduce the chances of human errors.

Lack of adoption of automated solutions by small-scale and medium-scale laboratories

Medium and small-scale laboratories handle a lower volume of samples as they are mostly established to address specific applications such as diagnosis and testing of biological samples. These laboratories lack adequate budgets. staff, or planning. Therefore, they do not prioritize automation. Moreover, small-and medium-scale laboratories are reluctant to procure laboratory automation systems due to lack of floor space.

For the detailed list of factors that will drive and challenge the growth of the laboratory automation systems market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be mildly fragmented and with the presence of several companies. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Pharmaceutical and biotechnology companies - Market size and forecast 2018-2023
  • Clinical and reference laboratories - Market size and forecast 2018-2023
  • Academic institutes and research organizations - Market size and forecast 2018-2023
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Agilent Technologies
  • Danaher
  • PerkinElmer
  • QIAGEN
  • Thermo Fisher Scientific

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations

PART 15: EXPLORE TECHNAVIO

List of Exhibits

  • Exhibit 01: Global healthcare market
  • Exhibit 02: Segments of global healthcare market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: End-user - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by end-user
  • Exhibit 19: Pharmaceutical and biotechnology companies - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 20: Pharmaceutical and biotechnology companies - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Clinical and reference laboratories - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: Clinical and reference laboratories - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Academic institutes and research organizations - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 24: Academic institutes and research organizations - Year-over-year growth 2019-2023 (%)
  • Exhibit 25: Market opportunity by end-user
  • Exhibit 26: Customer landscape
  • Exhibit 27: Market share by geography 2018-2023 (%)
  • Exhibit 28: Geographic comparison
  • Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 37: Key leading countries
  • Exhibit 38: Market opportunity
  • Exhibit 39: Impact of drivers and challenges
  • Exhibit 40: Vendor landscape
  • Exhibit 41: Landscape disruption
  • Exhibit 42: Vendors covered
  • Exhibit 43: Vendor classification
  • Exhibit 44: Market positioning of vendors
  • Exhibit 45: Agilent Technologies - Vendor overview
  • Exhibit 46: Agilent Technologies - Business segments
  • Exhibit 47: Agilent Technologies - Organizational developments
  • Exhibit 48: Agilent Technologies - Geographic focus
  • Exhibit 49: Agilent Technologies - Segment focus
  • Exhibit 50: Agilent Technologies - Key offerings
  • Exhibit 51: Danaher - Vendor overview
  • Exhibit 52: Danaher - Business segments
  • Exhibit 53: Danaher - Organizational developments
  • Exhibit 54: Danaher - Geographic focus
  • Exhibit 55: Danaher - Segment focus
  • Exhibit 56: Danaher - Key offerings
  • Exhibit 57: PerkinElmer - Vendor overview
  • Exhibit 58: PerkinElmer - Business segments
  • Exhibit 59: PerkinElmer - Organizational developments
  • Exhibit 60: PerkinElmer - Geographic focus
  • Exhibit 61: PerkinElmer - Segment focus
  • Exhibit 62: PerkinElmer - Key offerings
  • Exhibit 63: QIAGEN - Vendor overview
  • Exhibit 64: QIAGEN - Business segments
  • Exhibit 65: QIAGEN - Organizational developments
  • Exhibit 66: QIAGEN - Geographic focus
  • Exhibit 67: QIAGEN - Segment focus
  • Exhibit 68: QIAGEN - Key offerings
  • Exhibit 69: Thermo Fisher Scientific - Vendor overview
  • Exhibit 70: Thermo Fisher Scientific - Business segments
  • Exhibit 71: Thermo Fisher Scientific - Organizational developments
  • Exhibit 72: Thermo Fisher Scientific - Geographic focus
  • Exhibit 73: Thermo Fisher Scientific - Segment focus
  • Exhibit 74: Thermo Fisher Scientific - Key offerings
Back to Top